Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 710.471 million compared to CNY 398.337 million a year ago. Operating income was CNY 83.216 million compared to CNY 63.821 million a year ago. Net income was CNY 68.564 million compared to CNY 48.781 million a year ago. Basic earnings per share from continuing operations was CNY 0.07 compared to CNY 0.05 a year ago.